VISTA promotes the metabolism and differentiation of myeloid-derived suppressor cells by STAT3 and polyamine-dependent mechanisms
2024 · Cell Reports · 38 citations
https://doi.org/10.1016/j.celrep.2023.113661
H
Hana Husic
Cleveland Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
23
Papers
68
Citations
3
h-index
3
i10-index
Hana Husic is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Lung Cancer Treatments and Mutations & Cancer Research and Treatments. The author has an h-index of 3, co-authored 20 publications.
ORCID: 0000-0003-4016-2197Papers by this author
worksPhenotypic and molecular states of IDH1 mutation-induced CD24-positive glioma stem-like cells
2022 · Neoplasia · 16 citations
https://doi.org/10.1016/j.neo.2022.100790
Supplementary Figure S2 from Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer
2024 · 0 citations
https://doi.org/10.1158/1078-0432.24947905.v1
Data from Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer
2024 · 0 citations
https://doi.org/10.1158/1078-0432.c.7010479.v1
Supplementary Figure S5 from Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer
2024 · 0 citations
https://doi.org/10.1158/1078-0432.24947896.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat